AVANDIA2MG (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the AVANDIA drug offered from GlaxoSmithKline LLC. This Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | rosiglitazone maleate |
| SUBSTANCE NAME: | ROSIGLITAZONE MALEATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-05-25 |
| END MARKETING DATE: | 0000-00-00 |
AVANDIA 2MG HUMAN PRESCRIPTION DRUG Details:
| Item Description | AVANDIA 2MG from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/1) |
| START MARKETING DATE: | 2011-05-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0173-0861_a2d252f9-4a59-4151-a904-f8676bfcd22d |
| PRODUCT NDC: | 0173-0861 |
| APPLICATION NUMBER: | NDA021071 |
Other ROSIGLITAZONE MALEATE Pharmaceutical Manufacturers / Labelers:
